ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 01 Mar 2021
Last Applicant/ Owned by
Regeringsgatan 111
Stockholm
SE
11139
Serial Number
88576525 filed on 13th Aug 2019
Registration Number
N/A
Correspondent Address
Donna J. Bunton
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
OXABACT
Pharmaceutical preparations for use in urology, gastroenterology, oncology and immunology and for the treatment of diabetes, infectious diseases, inflammation and metabolic diseases, all for therapeutic use; pharmaceutical preparations for the treatment of kidney stones; pharmaceutical products for the treatment and prevention of kidney diseases in patients with hyperoxaluria
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for use in urology, gastroenterology, oncology and immunology and for the treatment of diabetes, infectious diseases, inflammation and metabolic diseases, all for therapeutic use; pharmaceutical preparations for the treatment of kidney stones; pharmaceutical products for the treatment and prevention of kidney diseases in patients with hyperoxaluria
Mark Details
Serial Number
No 88576525
Mark Type
No Service/Collective Mark
Attorney Docket Number
No DJB/2739-179
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 01st Mar 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 01st Mar 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| 28th Jul 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 02th Jun 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 02th Jun 2020 | PUBLISHED FOR OPPOSITION |
| 13th May 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 28th Apr 2020 | ASSIGNED TO LIE |
| 21st Apr 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 17th Apr 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 17th Apr 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |